COMP <GO>
CNMD vs LIVN // FORWARD P/E MULTIPLE
CONMED Corporation (NYSE) VS. LivaNova PLC (NASDAQ) • 15-METRIC TALLY: CNMD 4
— LIVN 7
■ METRIC PARITY
LAST: $45.72 (-0.09%) • MKT CAP: $1.36B
forward-pe
26.9x
LAST: $81.25 (+0.73%) • MKT CAP: $4.48B
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNMD VS. LIVN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNMD | LIVN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.60% | 67.70% | -13.10 | LIVN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 17.30% | -9.50 | LIVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.4x | 15.6x | -4.20 | CNMD | /valuation <GO> |
| Free Cash Flow Yield | 11.07% | 3.87% | +7.20 | CNMD | /fcf-yield <GO> |
| Operating Margin | 7.50% | 14.40% | -6.90 | LIVN | /operating-margins <GO> |
| Net Profit Margin | 3.40% | -17.50% | +20.90 | CNMD | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | 10.70% | -5.50 | LIVN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.82% | 0.00% | +1.82 | CNMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.91 | 2.21 | -0.30 | LIVN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.6 | 50.8 | -10.21 | LIVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 26.9x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.36B | $4.48B | -$3.11B | LIVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNMD REV | LIVN REV | CNMD GROSS % | LIVN GROSS % | CNMD FCF | LIVN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.37B | $1.39B | 54.6% | 67.7% | $150.9M | $173.3M |
| FY 2024 | $1.31B | $1.25B | 56.1% | 68.1% | $153.9M | $135.9M |
| FY 2023 | $1.24B | $1.15B | — | — | $125.3M | $74.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNMD // BETA —
LIVN // BETA —